Effect of systemic LPS injection on cortical NF-kappaB activity and inflammatory response following traumatic brain injury in rats

Brain Res. 2004 Nov 5;1026(1):23-32. doi: 10.1016/j.brainres.2004.07.090.

Abstract

The aim of current study is to investigate the effect of systemic administration of lipopolysaccharide (LPS) on the temporal pattern of cortical nuclear factor kappa B (NF-kappaB) binding activity, inflammatory response and secondary damage in the injured brain following traumatic brain injury (TBI). Right parietal cortical contusion in rats was made by using weight-dropping method. The rats were randomly divided into sham, LPS, TBI and TBI-LPS groups, with LPS injected intraperitoneally. NF-kappaB binding activity, cytokines, intercellular adhesion molecule-1 (ICAM-1) and brain damage were detected by electrophoretic mobility shift assay (EMSA), enzyme-linked immunosorbent assay (ELISA), immunohistochemistry and terminal deoxynucleotidyl-transferase-mediated biotin-dUTP nick end labeling (TUNEL) apoptosis, respectively. The results showed that systemic administration of LPS following TBI could induce an immediate, strong and persistent upregulation of NF-kappaB, tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6) and ICAM-1 in the area surrounding the injured brain. As compared with rats of sham, LPS and TBI groups, NF-kappaB binding activity, TNF-alpha and IL-6 were significantly upregulated in the surrounding cortex of injured site as early as 3 h postinjury when challenged with LPS, kept at high level up to 7-days postinjury. ICAM-1-positive vessels and apoptotic TUNEL-positive cells in the injured brain were also significantly increased in TBI-LPS rats. It was concluded that inflammatory response and secondary brain damage occurred in the injured brain could be highly exacerbated by endotoxemia.

Publication types

  • Comparative Study

MeSH terms

  • Analysis of Variance
  • Animals
  • Apoptosis / physiology
  • Brain Injuries / complications
  • Brain Injuries / metabolism*
  • Brain Injuries / pathology
  • Cell Count / methods
  • Cerebral Cortex / drug effects*
  • Cerebral Cortex / metabolism
  • Cerebral Cortex / pathology
  • Disease Models, Animal
  • Electrophoretic Mobility Shift Assay / methods
  • Enzyme-Linked Immunosorbent Assay / methods
  • Immunohistochemistry / methods
  • In Situ Nick-End Labeling / methods
  • Inflammation / etiology
  • Inflammation / metabolism*
  • Intercellular Adhesion Molecule-1 / metabolism
  • Interleukin-6 / metabolism
  • Lipopolysaccharides / administration & dosage
  • Lipopolysaccharides / pharmacology*
  • Male
  • NF-kappa B / metabolism*
  • Random Allocation
  • Rats
  • Rats, Wistar
  • Time Factors
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Interleukin-6
  • Lipopolysaccharides
  • NF-kappa B
  • Tumor Necrosis Factor-alpha
  • Intercellular Adhesion Molecule-1